Shenzhen yingfeiyuan Technology Co., Ltd – Trademark Portfolio
Entity Type: 99
Shenzhen yingfeiyuan Technology Co., Ltd holds 1 U.S. trademark filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 9 (Computers & Electronics) — 1 filings in this category. The portfolio also extends into Class 10 (Medical Apparatus) across 2 Nice Classification classes. Currently, 1 trademark is registered. Notable registered marks include INFIWARDEN. The owner is based in District, Shenzhen.
606, building 2, No.54-6 Guanlan Avenue,
District, Shenzhen 518000 , CN
Showing of trademarks Trademarks
Trademark Classifications
Shenzhen yingfeiyuan Technology Co., Ltd's trademark portfolio spans 2 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Scientific, nautical, surveying, photographic, cinematographic, optical apparatus and instruments
Frequently Asked Questions
How many trademarks does Shenzhen yingfeiyuan Technology Co., Ltd have?
Shenzhen yingfeiyuan Technology Co., Ltd has 1 U.S. trademark filed with the USPTO. Of these, 1 registered.
What trademark classes does Shenzhen yingfeiyuan Technology Co., Ltd file in?
Shenzhen yingfeiyuan Technology Co., Ltd files trademarks across 2 Nice Classification classes. The most active classes are Class 9 (Computers & Electronics), Class 10 (Medical Apparatus). Class 9 covers scientific, nautical, surveying, photographic, cinematographic, optical apparatus and instruments.
What are Shenzhen yingfeiyuan Technology Co., Ltd's most well-known trademarks?
Shenzhen yingfeiyuan Technology Co., Ltd's registered trademark portfolio includes well-known marks such as INFIWARDEN. These are among 1 currently registered trademark in the portfolio.
What is Shenzhen yingfeiyuan Technology Co., Ltd's trademark registration success rate?
Shenzhen yingfeiyuan Technology Co., Ltd has a 100% trademark registration rate, with 1 out of 1 resolved applications resulting in successful registration. Currently, 0 applications are pending review.